ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: a randomised crossover pharmacokinetic study
British Journal of Clinical Pharmacology
◽
10.1111/bcp.14886
◽
2021
◽
Author(s):
Christopher G. C. A. Jackson
◽
Tak Hung
◽
Eva Segelov
◽
Paula Barlow
◽
Hans Prenen
◽
...
Keyword(s):
Advanced Cancer
◽
Pharmacokinetic Study
◽
Oral Paclitaxel
Download Full-text
Related Documents
Cited By
References
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: a randomised crossover pharmacokinetic study.
10.22541/au.160253837.73597117/v1
◽
2020
◽
Author(s):
Christopher Jackson
◽
Tak Hung
◽
Eva Segelov
◽
Paula Barlow
◽
Hans Prenen
◽
...
Keyword(s):
Advanced Cancer
◽
Pharmacokinetic Study
◽
Oral Paclitaxel
Download Full-text
Faculty Opinions recommendation of Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1043078.492991
◽
2006
◽
Author(s):
Jeffrey Evans
Keyword(s):
Protein Kinase C
◽
Protein Kinase
◽
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
◽
Dose Escalation
◽
Kinase C
◽
Protein Kinase C Beta
Download Full-text
Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s002800000115
◽
2000
◽
Vol 46
(1)
◽
pp. 43-50
◽
Cited By ~ 15
Author(s):
John R. Murren
◽
Kathleen Peccerillo
◽
Susan A. DiStasio
◽
Xin Li
◽
Janine J. Leffert
◽
...
Keyword(s):
Advanced Cancer
◽
Pharmacokinetic Study
◽
Dose Escalation
Download Full-text
Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer
Journal of Clinical Oncology
◽
10.1200/jco.2007.14.9633
◽
2008
◽
Vol 26
(18)
◽
pp. 3051-3056
◽
Cited By ~ 53
Author(s):
Patricia M. LoRusso
◽
Suzanne F. Jones
◽
Kevin M. Koch
◽
Nikita Arya
◽
Ronald A. Fleming
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
Download Full-text
Pilot Clinical and Pharmacokinetic Study of Δ9-Tetrahydrocannabinol and Cannabidiol Oro-Buccal Spray in Advanced Cancer with Uncontrolled Pain.
10.22541/au.159969847.76735495
◽
2020
◽
Author(s):
Stephen Clarke
◽
Belinda Butcher
◽
Andrew McLachlan
◽
Jeremy Henson
◽
David Rutolo
◽
...
Keyword(s):
Advanced Cancer
◽
Pharmacokinetic Study
Download Full-text
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-006-0240-7
◽
2006
◽
Vol 59
(1)
◽
pp. 79-87
◽
Cited By ~ 26
Author(s):
R. O’Connor
◽
M. O’Leary
◽
J. Ballot
◽
C. D. Collins
◽
P. Kinsella
◽
...
Keyword(s):
Drug Resistance
◽
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
◽
Multi Drug Resistance
◽
Resistance Protein
Download Full-text
A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer
Investigational New Drugs
◽
10.1007/s10637-005-1439-x
◽
2005
◽
Vol 23
(4)
◽
pp. 311-315
◽
Cited By ~ 24
Author(s):
Kim N. Chi
◽
Stephen K. Chia
◽
Ross Dixon
◽
Michael J. Newman
◽
Vince J. Wacher
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
◽
P Glycoprotein
Download Full-text
A phase I and pharmacokinetic study of rubitecan, an orally administered topoisomerase I (topo-I) inhibitor, combined with gemcitabine in patients with advanced cancer
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.2099
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 2099-2099
◽
Cited By ~ 1
Author(s):
E. Calvo
◽
E. K. Rowinsky
◽
A. W. Tolcher
◽
Q. S. Chu
◽
M. Beeram
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
◽
Topoisomerase I
Download Full-text
Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s002800100317
◽
2001
◽
Vol 48
(2)
◽
pp. 95-103
◽
Cited By ~ 29
Author(s):
Pankaj Bhargava
◽
John Marshall
◽
Karen Fried
◽
Marion Williams
◽
Patricia Lefebvre
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
Download Full-text
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
Annals of Oncology
◽
10.1093/annonc/mdi318
◽
2005
◽
Vol 16
(10)
◽
pp. 1695-1701
◽
Cited By ~ 45
Author(s):
A.H.G. Hansma
◽
H.J. Broxterman
◽
I. van der Horst
◽
Y. Yuana
◽
E. Boven
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Pharmacokinetic Study
◽
Intravenous Infusion
◽
Continuous Intravenous Infusion
◽
Recombinant Human Endostatin
◽
Subcutaneous Injections
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close